NIVF
NIVF
NASDAQ · Health Care

Newgenivf Group Ltd-A

$2.26
+0.31 (+15.90%)
As of Mar 31, 10:17 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.03B
Net Income
-196,299,042
Gross Margin
33.6%
Profit Margin
-9.7%
Rev Growth
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.6% 63.4% 63.4% 63.4%
Operating Margin -21.4% 15.0% 13.3% 13.3%
Profit Margin -9.7% 10.4% 12.9% 12.1%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.03B 401.7K 362.7K 344.3K
Gross Profit 683.48M 254.9K 230.1K 218.5K
Operating Income -434,238,277 60.1K 48.3K 45.7K
Net Income -196,299,042 41.8K 46.7K 41.5K
Gross Margin 33.6% 63.4% 63.4% 63.4%
Operating Margin -21.4% 15.0% 13.3% 13.3%
Profit Margin -9.7% 10.4% 12.9% 12.1%
Rev Growth +17.6% -6.2% -6.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 989 153.4K 184.7K 169.1K
Total Equity 581.8K 435.1K 422.0K 475.1K
D/E Ratio 0.00 0.35 0.44 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -63,457,424 62.8K 66.4K 61.5K
Free Cash Flow 54.6K 52.4K 38.3K